DOMPE
Marc Vallee is an experienced professional in the field of biostatistics and biometrics, currently serving as the Vice President and Head of Biometrics at Dompé since February 2025. Prior to this role, Marc held a similar position at BlueRock Therapeutics from April 2023 to February 2025. Marc's extensive background includes senior leadership roles as Senior Director of Biostatistics at Deciphera Pharmaceuticals (August 2020 - April 2023) and Director of Biostatistics at Alexion Pharmaceuticals, Inc. (September 2012 - August 2020). Marc began a career in biostatistics at Genzyme and has also worked at the Duke Clinical Research Institute and the Harvard School of Public Health. Academic credentials include a Master of Science in Statistics from The University of British Columbia and a Bachelor of Science in Mathematics from Université de Montréal.
This person is not in any teams
This person is not in any offices
DOMPE
2 followers
DOMPE is a biopharmaceutical company that is committed to research and development to meet unsatisfied therapeutic needs. The company's products are engaged in the development and distribution of ethical drugs and self-medication, adjuvants, medical devices and cosmetics, and in the fields of vitamin and mineral supplements and personalhygiene. The therapeutic areas include cardiovascular, gastrointestinal, pediatrics, neurology, urology, ophthalmic, stomatology, and respiratory.Founded in 1940, Dompe is headquartered in Milan, Italy.